Cabaletta Bio
CABA
CABA
159 hedge funds and large institutions have $871M invested in Cabaletta Bio in 2024 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 46 increasing their positions, 47 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
22% less capital invested
Capital invested by funds: $1.11B → $871M (-$240M)
43% less call options, than puts
Call options by funds: $8.87M | Put options by funds: $15.6M
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
159
Holding in Top 10
2
Calls
$8.87M
Puts
$15.6M
Top Buyers
| 1 | +$30.6M | |
| 2 | +$19.6M | |
| 3 | +$18.8M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$10.9M |
| 5 |
SC
Stempoint Capital
New York
|
+$9.44M |
Top Sellers
| 1 | -$43.6M | |
| 2 | -$17.1M | |
| 3 | -$15.9M | |
| 4 |
CC
Commodore Capital
New York
|
-$13.6M |
| 5 |
DM
Deerfield Management
New York
|
-$12.8M |